Health-related quality of life in survivors of septic shock: 6-month follow-up from the ADRENAL trial

Purpose To investigate the impact of hydrocortisone treatment and illness severity on health-related quality of life (HRQoL) at 6 months in septic shock survivors from the ADRENAL trial. Methods Using the EuroQol questionnaire (EQ-5D-5L) at 6 months after randomization we assessed HRQoL in patient s...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Intensive care medicine 2020-09, Vol.46 (9), p.1696-1706
Hauptverfasser:	Hammond, Naomi E., Finfer, Simon R., Li, Qiang, Taylor, Colman, Cohen, Jeremy, Arabi, Yaseen, Bellomo, Rinaldo, Billot, Laurent, Harward, Meg, Joyce, Christopher, McArthur, Colin, Myburgh, John, Perner, Anders, Rajbhandari, Dorrilyn, Rhodes, Andrew, Thompson, Kelly, Webb, Steve, Venkatesh, Balasubramanian
Format:	Artikel
Sprache:	eng
Schlagworte:	Adrenal glands Anesthesiology Bacteremia Care and treatment Catecholamine Catecholamines Critical Care Medicine Domains Emergency Medicine Female Follow-Up Studies Gender Health Status Humans Hydrocortisone Illnesses Intensive Intensive care Male Medical research Medicine Medicine & Public Health Medicine, Experimental Mobility Original Pain Pain Medicine Pediatrics Pneumology/Respiratory System Quality of Life Randomization Sepsis Septic shock Shock, Septic - drug therapy Subgroups Surveys and Questionnaires Survival Survivors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Purpose To investigate the impact of hydrocortisone treatment and illness severity on health-related quality of life (HRQoL) at 6 months in septic shock survivors from the ADRENAL trial. Methods Using the EuroQol questionnaire (EQ-5D-5L) at 6 months after randomization we assessed HRQoL in patient subgroups defined by hydrocortisone or placebo treatment, gender, illness severity (APACHE II
ISSN:	0342-4642 1432-1238
DOI:	10.1007/s00134-020-06169-1